-
More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand Godha
expresspharma
October 10, 2020
Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories.
-
Majority of generic drug ingredients produced in Asia – study
expresspharma
October 10, 2020
Industry players warn bringing production home may be a complicated process, saying higher labour costs and tougher environmental standards make it impossible to compete with Asian suppliers on price.
-
Research finds 25 percent of drugs contain highly potent compounds
europeanpharmaceuticalreview
September 27, 2020
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.
-
India ramping up API manufacturing: NITI Aayog CEO
expresspharma
September 17, 2020
Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug discovery, innovation, and drug manufacturing, said Kant.
-
CORONA Remedies picks up stake in La Chandra Pharmalab
expresspharma
September 08, 2020
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs.
-
Piramal to Deliver Integrated Services to Epirium
contractpharma
August 28, 2020
Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
-
NPPA rejects IPA request for upward price revision of five per cent on all drugs
expresspharma
August 20, 2020
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19 period, but it does not validate the claim of IPA for a price increase.
-
India’s CMO market is hotbed for global PE investment: GlobalData
expresspharma
August 18, 2020
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small molecule API hotspots such as in the US and China.
-
Ipca Labs is setting up API manufacturing facility in Dewas, MP
expresspharma
August 17, 2020
It is in the process of procuring environmental clearance for the new plant being built with an initial capital outlay of about Rs 250 crores.
-
Lee Pharma to launch favipiravir under brand name Faravir at Rs 27 per tablet
expresspharma
August 17, 2020
Hyderabad-based, Lee Pharma has received DCGI’s approval for manufacturing and marketing of active pharmaceutical ingredients (API) for favipiravir in India.